Quality of life following high‐intensity focused ultrasound for the treatment of localized prostate cancer: A prospective study
- 22 July 2010
- journal article
- clinical trial
- Published by Wiley in International Journal of Urology
- Vol. 17 (8), 715-719
- https://doi.org/10.1111/j.1442-2042.2010.02568.x
Abstract
To report our health-related quality of life (QOL) and functional outcomes following high-intensity focused ultrasound (HIFU) for localized prostate cancer. Data from prostate cancer patients undergoing HIFU at our institution between January 1999 and April 2007 were collected in our prospective database. Standard preoperative and surgical parameters, as well as baseline urinary function, QOL and sexual assessment were included. The Japanese version of the Functional Assessment of Cancer Therapy-general (FACT-G), the FACT-prostate (P) and the International Index of Erectile Function-5 (IIEF-5) were used for the functional assessment. These self-administered questionnaires were collected preoperatively and again at 6, 12 and 24 months postoperatively. A total of 326 patients were included in the analysis. Maximum flow rate and residual urine volume were significantly impaired at 6 months (P = 0.010) after HIFU, even if they returned to baseline values at 12 or 24 months after HIFU. The total FACT-G score significantly improved at 24 months (P = 0.027) after HIFU. At 6, 12 and 24 months after HIFU, 52%, 63% and 78%, respectively, of the patients, not receiving neoadjuvant hormonal therapy, were potent. In our experience, functional and QOL outcomes after HIFU therapy for localized prostate cancer are better than those after other treatment modalities.Keywords
This publication has 17 references indexed in Scilit:
- Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: Eight-year experienceInternational Journal of Urology, 2009
- Factors Predicting for Formation of Bladder Outlet Obstruction After High-Intensity Focused Ultrasound in Treatment of Localized Prostate CancerUrology, 2008
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus ConferenceInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Patients’ Perceptions of Quality of Life After Treatment for Early Prostate CancerJournal of Clinical Oncology, 2003
- The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resectionCurrent Urology Reports, 2003
- The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunctionInternational Journal Of Impotence Research, 2002
- Cross-cultural validation of an international questionnaire, the General Measure of the Functional Assessment of Cancer Therapy scale (FACT-G), for JapaneseQuality of Life Research, 2001
- Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-prostate instrumentUrology, 1997
- The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunctionUrology, 1997
- The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.Journal of Clinical Oncology, 1993